Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    How to assess and counsel the older driver
    Barbara J. Messinger-Rapport, MD, PhD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 184-192;

    Suggesting that a patient stop driving is never easy, yet taking no action may have deadly consequences.

  • You have access
    The B-type natriuretic peptide assay: A rapid test for heart failure
    W. Frank Peacock, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 243-251;

    This 15-minute test is highly sensitive and fairly specific and is useful in evaluating suspected heart failure in outpatients and in emergency care.

  • What is hemochromatosis?
    You have access
    What is hemochromatosis?
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 238;
  • You have access
    Hereditary hemochromatosis: A common, often unrecognized, genetic disease
    Geraldine M. McCarthy, MD, Conor J. McCarthy, MD, Dermot Kenny, MD, John Crowe, MD, PhD and Stephen Eustace, MB
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 224-237;

    Although hereditary hemochromatosis is one of the most common genetic diseases affecting people of northern European descent, it is underdiagnosed.

  • What is the best diagnostic approach when pheochromocytoma is suspected?
    You have access
    What is the best diagnostic approach when pheochromocytoma is suspected?
    Emmanuel L. Bravo, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 257-258;

    First prove there is catecholamine overproduction, then obtain an MRI to locate the tumor.

  • You have access
    Oncologic emergencies for the internist
    William S. Krimsky, MD, Robert J. Behrens, MD and Gary J. Kerkvliet, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 209-222;

    The complications the general internist is most likely to see and can least afford to miss.

  • You have access
    Hereditary hemochromatosis: Molecular genetic testing issues for the clinician
    Brian A. Clark, PhD, MD
    Cleveland Clinic Journal of Medicine March 2002, 69 (3) 239-242;

    A DNA test exists, but who should be tested?

  • You have access
    Advances in treatment of chronic hepatitis C: ‘Pegylated’ interferons
    Khavir A. Sharieff, DO, David Duncan, MD and Zobair Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine February 2002, 69 (2) 155-159;

    New formulations of interferon alfa that incorporate polyethylene glycol in the drug molecule are an important advance in the treatment of chronic hepatitis C.

  • You have access
    Tired, aching, ANA-positive: Does your patient have lupus or fibromyalgia?
    David E. Blumenthal, MD
    Cleveland Clinic Journal of Medicine February 2002, 69 (2) 143-152;

    Do not rely on the antinuclear antibody test to make the distinction between fibromyalgia and lupus.

  • You have access
    Idiopathic retroperitoneal fibrosis: Prompt diagnosis preserves organ function
    Stefan Monev, MD
    Cleveland Clinic Journal of Medicine February 2002, 69 (2) 160-165;

    The chief dangers from idiopathic retroperitoneal fibrosis— ureteral obstruction with loss of renal function, and other organ involvement—are avoidable and treatable with prompt diagnosis.

Pages

  • Previous
  • Next
  • 1
  • …
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398
  • 399
  • 400
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire